0001778151-20-000001.txt : 20200319 0001778151-20-000001.hdr.sgml : 20200319 20200319160003 ACCESSION NUMBER: 0001778151-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 EFFECTIVENESS DATE: 20200319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Seneca Therapeutics, Inc. CENTRAL INDEX KEY: 0001778151 IRS NUMBER: 824541163 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-354090 FILM NUMBER: 20728400 BUSINESS ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 484-883-9725 MAIL ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 D/A 1 primary_doc.xml X0708 D/A LIVE 0001778151 Seneca Therapeutics, Inc. 202 ST. ANDREWS COURT BLUE BELL PA PENNSYLVANIA 19422 484-883-9725 DELAWARE None None Corporation true 2018 Paul Hallenbeck 202 St. Andrews Court Blue Bell PA PENNSYLVANIA 19422 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001778151-19-000003 2020-03-12 false true true true false 0 Walter Greenblatt & Associates, LLC 129291 None None 327 St. Marks Avenue Brooklyn NY NEW YORK 11238 CT CONNECTICUT FL FLORIDA NJ NEW JERSEY PA PENNSYLVANIA false 1000000 820000 180000 false 14 70000 true 0 Sales commissions will be $70,000 if the total offering amount is sold. 33666 true false Seneca Therapeutics, Inc. Paul Hallenbeck Paul Hallenbeck President 2020-03-12